Nuntius Therapeutics

Company Intelligence

Press

• Nuntius Therapeutics Announces Collaboration with Taiho Pharmaceutical to Develop Next-Generation mRNA Therapies Using Nuntius’ Proprietary Cell-Specific Delivery TechnologyBusiness Wire · 8/15/2024
• Precision Targeting of Myeloid Cells via Peptide Dendrimer-Lipid Nanocarriers: A Novel Platform for Potent Cancer ImmunotherapiesWiley & Sons · 9/19/2025

Signals

• Pressurl: https://news.google.com/rss/articles/CBMizgJBVV95cUxQUk4zbzJSNVJoZC1WVS1FSEJ6YUlkSGJEZVdXeUJvMEZLd2doVi1wWW5zQ3VHX3NVUzFURVdOZTgzRllKOS1NVHhfWXBEVVNyVVVHVVFYRXYyN2R4cmZTYlBldXdyemJxeUtvUlpMU0JxVm9MSkxhNXB3WnhWWHpUbjlXbWFUN29RWFY0cTJjTXFJQUZZdVFyVUV6cmNBYlZpWkJDazA4UG9NNFFXMVBVMGk5c1B5TzJCLTc1cklwU2RDNzZUQkpKZHBzdnMwODRPUWVzZy1ud0trQXYwdjk2ZUljVU9jVTRWYi1sV3dGb0U3bFl0MmxEX0ZaTncwM2NRNWNCY2I3WkJ6T2xNMVZ5MnVhRjI2OGJiUEUwZHpOTW51WlF6SkQ3X19fSXI1QXpfQkpqWUR4elVfNXZrc1VLMUtISDNxeUdHeHNQR1ZB?oc=5 · headline: Nuntius Therapeutics Announces Collaboration with Taiho Pharmaceutical to Develop Next-Generation mRNA Therapies Using Nuntius’ Proprietary Cell-Specific Delivery Technology · publication: Business Wiregoogle_news · 9/15/2026
• Pressurl: https://news.google.com/rss/articles/CBMie0FVX3lxTFBtZkNib0VRcnJVcEtweWlNV2wwdFlRaklCOFIwdm9ROFZFVzg3Z2NEdU15YmlxMjQ2M216RTR4UVdDYTFXV2djQU0xaGRfa3NIQTBrZDloeHBqTk13czMwc2VlQWRwRldlYTF6Zk5wREx0SWZ4aFpuNFduRQ?oc=5 · headline: Precision Targeting of Myeloid Cells via Peptide Dendrimer-Lipid Nanocarriers: A Novel Platform for Potent Cancer Immunotherapies · publication: Wiley & Sonsgoogle_news · 9/15/2026